EFFECTS OF LOCAL BACILLUS CALMETTE-GUERIN THERAPY IN PATIENTS WITH BLADDER-CARCINOMA ON IMMUNOCOMPETENT CELLS OF THE BLADDER WALL

被引:176
作者
BOHLE, A [1 ]
GERDES, J [1 ]
ULMER, AJ [1 ]
HOFSTETTER, AG [1 ]
FLAD, HD [1 ]
机构
[1] BORSTEL RES INST,DEPT IMMUNOL & CELL BIOL,BORSTEL,GERMANY
关键词
D O I
10.1016/S0022-5347(17)39365-5
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The antitumoral effects of intravesical bacillus Calmette-Guerin against recurrent superficial urothelial bladder cancer seem to be linked to immunological effector mechanisms. To characterize further the local cellular response in the bladder wall of patients receiving intravesical bacillus Calmette-Guerin bladder biopsies were examined before and immediately after a 6-week course of bacillus Calmette-Guerin and for up to 1 year at 3-month intervals thereafter. The results showed a marked infiltration after bacillus Calmette-Guerin therapy predominantly of the suburothelial tissue with mononuclear cells, which expressed activation markers and accumulated to follicle-like granulomatous structures. With regard to T lymphocyte subsets the ratio of T helper-to-T suppressor cells in the bladder wall increased from 0.5 to nearly 2. This phenomenon persisted even in biopsies 1 year after initial treatment. In some probes activated mononuclear cells invaded the urothelium, emanating from suburothelial granulomas. It is tempting to assume that these changes within the local immunocompetent cells are related to the therapeutic effect of bacillus Calmette-Guerin against bladder cancer.
引用
收藏
页码:53 / 58
页数:6
相关论文
共 40 条
  • [1] ADOLPHS HD, 1984, UROL RES, V12, P129
  • [2] A PROSPECTIVE RANDOMIZED TRIAL OF MAINTENANCE VERSUS NONMAINTENANCE INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY OF SUPERFICIAL BLADDER-CANCER
    BADALAMENT, RA
    HERR, HW
    WONG, GY
    GNECCO, C
    PINSKY, CM
    WHITMORE, WF
    FAIR, WR
    OETTGEN, HF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (03) : 441 - 449
  • [3] ELEVATIONS OF CYTOKINES INTERLEUKIN-1, INTERLEUKIN-2 AND TUMOR-NECROSIS-FACTOR IN THE URINE OF PATIENTS AFTER INTRAVESICAL BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY
    BOHLE, A
    NOWC, C
    ULMER, AJ
    MUSEHOLD, J
    GERDES, J
    HOFSTETTER, AG
    FLAD, HD
    [J]. JOURNAL OF UROLOGY, 1990, 144 (01) : 59 - 64
  • [4] EXPERIENCE WITH BACILLUS CALMETTE-GUERIN IN PATIENTS WITH SUPERFICIAL BLADDER-CARCINOMA
    BROSMAN, SA
    [J]. JOURNAL OF UROLOGY, 1982, 128 (01) : 27 - 30
  • [5] THE USE OF BACILLUS CALMETTE-GUERIN IN THE THERAPY OF BLADDER-CARCINOMA INSITU
    BROSMAN, SA
    [J]. JOURNAL OF UROLOGY, 1985, 134 (01) : 36 - 39
  • [6] RISKS AND BENEFITS OF REPEATED COURSES OF INTRAVESICAL BACILLUS CALMETTE-GUERIN THERAPY FOR SUPERFICIAL BLADDER-CANCER
    CATALONA, WJ
    HUDSON, MA
    GILLEN, DP
    ANDRIOLE, GL
    RATLIFF, TL
    [J]. JOURNAL OF UROLOGY, 1987, 137 (02) : 220 - 224
  • [7] IMMUNOENZYMATIC LABELING OF MONOCLONAL-ANTIBODIES USING IMMUNE-COMPLEXES OF ALKALINE-PHOSPHATASE AND MONOCLONAL ANTI-ALKALINE PHOSPHATASE (APAAP COMPLEXES)
    CORDELL, JL
    FALINI, B
    ERBER, WN
    GHOSH, AK
    ABDULAZIZ, Z
    MACDONALD, S
    PULFORD, KAF
    STEIN, H
    MASON, DY
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1984, 32 (02) : 219 - 229
  • [8] BACILLUS CALMETTE-GUERIN IN THE MANAGEMENT OF BLADDER-CANCER
    DROLLER, MJ
    [J]. JOURNAL OF UROLOGY, 1986, 135 (02) : 331 - 333
  • [9] LOCAL IMMUNE-RESPONSES AFTER INTRAVESICAL BCG TREATMENT FOR CARCINOMA INSITU
    ELDEMIRY, MIM
    SMITH, G
    RITCHIE, AWS
    JAMES, K
    CUMMING, JA
    HARGREAVE, TB
    CHISHOLM, GD
    [J]. BRITISH JOURNAL OF UROLOGY, 1987, 60 (06): : 543 - 548
  • [10] GARDINER RA, 1986, BRIT J UROL, V58, P19, DOI 10.1111/j.1464-410X.1986.tb05420.x